Jazz Pharmaceuticals (JAZZ) Director Jennifer E. Cook Sells 1,706 Shares

What Happened

• Jennifer E. Cook, a director of Jazz Pharmaceuticals plc, had a total of 1,706 shares disposed on 2026-08-31 as tax-withholding related to the vesting of previously granted restricted stock units (RSUs). The transactions consisted of 1,692 shares sold at $241.39 each (proceeds $408,432) and 14 shares sold at $244.06 each (proceeds $3,417), for combined proceeds of approximately $411,849. These were disposals to satisfy tax obligations (code F), not open-market purchases.

Key Details

• Transaction dates and prices:
  • 2026-08-31: 1,692 shares @ $241.39 = $408,432 (disposed)
  • 2026-08-31: 14 shares @ $244.06 = $3,417 (disposed)
• Total shares sold: 1,706; total proceeds: ~$411,849
• Filing: Report filed with SEC on 2026-09-02 covering the 2026-08-31 transactions.
• Shares owned after transaction: Not specified in the provided filing excerpt — consult the full Form 4 for post-transaction holdings.
• Footnote: F1 — Shares were sold to satisfy tax obligations arising out of the vesting of previously granted RSUs (i.e., sell-to-cover).

Context

• These transactions are routine tax-withholding sales tied to RSU vesting and are coded F; they typically do not signal a deliberate bullish or bearish view by the insider. For derivative or option exercises, the filing would note if shares were immediately sold; in this case the sale was solely to cover withholding on vested RSUs. Always check the full Form 4 for total holdings and any additional disclosures.